Recent approval by the Vaccine Alliance (Gavi) of a $1.8 billion African Vaccine Manufacturing Accelerator (AVMA), a financing instrument that will support sustainable vaccine manufacturing in Africa has been hailed as a game changer for the continent. "The targeted US$1 billion from Gavi to African manufacturers is a game changer for the continent and advances our efforts towards vaccine self-reliance," said Jean Kaseya, Africa CDC Director General in a press statement from the Africa CDC.

Source: News 24 December 31, 2023 09:19 UTC